This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Dermatopolymyositis
M13_DERMATOPOLY
dermatomyositis: Dermatomyositis (DM) is a type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
498 |
4. Check minimum number of eventsNone |
498 |
5. Include endpoints |
537 |
6. Filter based on genotype QC (FinnGen only) |
537 |
Control definitions (FinnGen only)
- Control exclude
- M13_SYSTCONNECT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M30-M36
- Name in latin
- Dermato[poly]myositis
Similar endpoints
↥List of similar endpoints to
Dermatopolymyositis
based on the number of shared cases.
Similar with more cases:
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Diseases of the musculoskeletal system and connective tissue
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 537 | 332 | 205 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.09 |
| Median age at first event (years) | 54.47 | 53.17 | 56.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 496
- Matched controls
- 4960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M33.2
ICD-10 Finland
Polymyositis
+∞
275.5
238
*
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
190.1
170
*
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
171.0
154
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
21.2
166.1
275
275
L04AX01
ATC
azathioprine; systemic
26.6
106.3
151
80
M60.9
ICD-10 Finland
Myositis, unspecified
189.5
103.7
105
7
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
12.6
98.1
195
242
H02AB06
ATC
prednisolone; systemic
8.3
94.1
396
1604
P01BA02
ATC
hydroxychloroquine; oral
13.0
85.2
163
180
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.6
82.3
316
1043
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
782.9
70.9
68
*
G72.9
ICD-10 Finland
Myopathy, unspecified
81.2
68.5
76
11
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
13.4
66.9
123
119
M05BA04
ATC
alendronic acid; oral
9.8
60.5
132
176
NXL00
NOMESCO Finland
Biopsy of muscle
143.8
60.4
63
5
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
218.2
57.3
58
*
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
+∞
54.1
51
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
168.4
44.6
46
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.9
43.1
97
131
L04AA06
ATC
mycophenolic acid; systemic
27.7
43.1
59
24
M60.8
ICD-10 Finland
Other myositis
101.1
42.6
46
5
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
40.1
38
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.3
39.1
114
224
H02AB07
ATC
prednisone; oral
4.7
36.9
147
411
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
35.9
34
*
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
8.7
31.8
71
93
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
31.6
30
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
31.5
282
1477
L04AD01
ATC
ciclosporin; systemic
17.0
30.1
48
31
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.7
28.9
70
104
M05BA07
ATC
risedronic acid; oral
11.2
25.1
48
47
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.7
24.8
75
150
L04AA01
ATC
[U] ciclosporin; systemic
15.7
23.3
38
26
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
23.1
22
*
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
22.0
21
*
L88
ICPC
Rheumatoid/seropositive arthritis
7.7
21.5
51
73
7104A
ICD-9 Finland
Diffuse diseases of connective tissue, Polymyositis
+∞
21.0
20
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
80.3
20.8
23
*
71610
ICD-8 Finland
Polymyositis and dermatomyositis, Polymyositis
+∞
19.9
19
*
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
19.9
19
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
19.9
188
937
M35.3
ICD-10 Finland
Polymyalgia rheumatica
14.9
18.8
31
22
R50.9
ICD-10 Finland
Fever, unspecified
3.4
18.8
102
353
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
10.4
17.9
35
36
L99
ICPC
Musculoskeletal disease other
12.1
17.8
32
28
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
17.0
147
684
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
11.3
16.7
31
29
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.7
16.3
38
53
R13
ICD-10 Finland
Dysphagia
4.6
16.1
57
135
C03CA01
ATC
furosemide; systemic
2.4
15.9
171
890
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
15.9
98
369
ZX120
NOMESCO Finland
Intravenous
3.5
15.7
78
251
XG410
NOMESCO Finland
Flow-volume spirometry
6.2
15.2
41
71
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.8
15.0
112
475
A02BC02
ATC
pantoprazole; systemic
2.2
14.8
338
2454
71600
ICD-8 Finland
Polymyositis and dermatomyositis, Dermatomyositis
+∞
14.6
14
*
G72.8
ICD-10 Finland
Other specified myopathies
11.9
14.4
26
23
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
15.0
14.2
23
16
XX9XE
NOMESCO Finland
Other ultrasound examination
18.2
13.9
21
12
E0000UV
ATC
NA
2.1
13.9
207
1240
R4110
NOMESCO Finland
Physiotherapy
2.3
13.8
157
830
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
13.6
61
180
7103B
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS ADULTORUM]
+∞
13.6
13
*
M33
ICD-10 Finland
Dermatopolymyositis
+∞
13.6
13
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
13.5
129
623
TGC00
NOMESCO Finland
Bronchial lavation
6.9
13.3
33
51
L28
ICPC
Limited function/disability (L)
2.7
13.1
99
422
XPX04
NOMESCO Finland
Angioscopy
51.4
12.9
15
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
12.7
120
574
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
12.7
73
261
R06.0
ICD-10 Finland
Dyspnoea
2.3
12.5
141
737
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.5
12.5
105
473
L19
ICPC
Muscle symptom/complaint NOS
7.1
12.1
29
43
JN4BD
NOMESCO Finland
Extensive body CT
2.9
11.9
79
308
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
66.5
11.7
13
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.0
11.5
46
123
N03AX16
ATC
pregabalin; oral
2.2
11.5
131
684
H05AA02
ATC
teriparatide; parenteral
44.3
11.0
13
*
R4120
NOMESCO Finland
Occupational therapy
3.6
10.9
50
151
H26.3
ICD-10 Finland
Drug-induced cataract
18.3
10.8
16
9
D07AC01
ATC
betamethasone; topical
2.0
10.7
178
1086
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
61.3
10.7
12
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.1
10.6
59
204
D07AB08
ATC
desonide; topical
2.8
10.5
71
279
E000001
ATC
NA
2.3
10.5
107
530
318
Kela drug reimbursment
Teriparatide
33.3
10.4
13
*
XA402
NOMESCO Finland
ENMG
5.3
10.2
30
59
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
9.9
119
633
A07AA02
ATC
nystatin; oral
3.4
9.9
48
152
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
9.9
64
246
C08CA05
ATC
nifedipine; systemic
3.3
9.8
49
159
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.7
9.7
42
121
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.5
9.6
44
133
NG4AA
NOMESCO Finland
Lower leg X-ray examination
5.3
9.2
27
53
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.0
9.0
28
59
Z50.1
ICD-10 Finland
Other physical therapy
3.8
8.9
37
103
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
8.9
55
205
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
8.9
202
1358
1XC02
NOMESCO Finland
NA
11.8
8.6
15
13
L93.0
ICD-10 Finland
Discoid lupus erythematosus
28.0
8.5
11
*
M13.9
ICD-10 Finland
Arthritis, unspecified
3.0
8.5
48
169
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.3
8.4
30
73
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
8.4
33
88
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
8.4
52
194
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
+∞
8.4
8
*
7103A
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS JUVENILIS]
+∞
8.4
8
*
H02AB04
ATC
methylprednisolone; systemic
2.3
8.3
80
381
XQ848
NOMESCO Finland
Dermatological photography
5.6
8.2
23
43
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.6
8.2
23
43
M05BX04
ATC
denosumab; parenteral
3.6
8.2
35
101
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
17.5
8.1
12
7
M05BA01
ATC
etidronic acid; systemic
33.9
8.1
10
*
M05BB03
ATC
alendronic acid and colecalciferol; oral
6.5
8.1
20
32
M81.4
ICD-10 Finland
Drug-induced osteoporosis
22.4
8.0
11
5
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
7.9
149
933
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.2
7.9
29
73
J01DB01
ATC
cefalexin; oral
1.9
7.9
388
3269
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.5
7.8
19
30
A02BC01
ATC
omeprazole; systemic
1.9
7.7
144
895
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
7.6
56
234
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
7.6
146
916
5BA08
NOMESCO Finland
NA
13.6
7.4
12
9
J05AB01
ATC
aciclovir; systemic
1.9
7.4
114
664
EBA10
NOMESCO Finland
Surgical removal of tooth
2.4
7.4
62
276
WZA10
NOMESCO Finland
Long statement of health and health related matters
8.5
7.4
15
18
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
11.1
7.3
13
12
M60.0
ICD-10 Finland
Infective myositis
+∞
7.3
7
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
7.3
7
*
D07AC13
ATC
mometasone; topical
1.8
7.3
142
895
C07AB07
ATC
bisoprolol; oral
1.7
7.2
222
1610
RF420
NOMESCO Finland
NA
6.7
7.2
17
26
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
7.1
66
310
A01AB09
ATC
miconazole; local oral
2.6
7.1
52
217
M05BA06
ATC
ibandronic acid; systemic
7.1
7.0
16
23
SPAT1231
SPAT
Assessment of adjustments needed in living environment
6.0
7.0
18
31
A28
ICPC
Limited function/disability NOS
2.1
6.9
76
386
XG466
NOMESCO Finland
Sleep oxymetry
4.3
6.9
24
58
RF410
NOMESCO Finland
NA
8.4
6.9
14
17
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
6.8
44
170
N28
ICPC
Limited function/disability (N)
6.2
6.8
17
28
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
6.8
54
236
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
40.6
6.8
8
*
J01FF01
ATC
clindamycin; systemic
1.8
6.8
132
830
M79.1
ICD-10 Finland
Myalgia
2.2
6.7
70
348
L29
ICPC
Musculoskeletal sympt/complt other
2.6
6.6
46
186
SPAT1229
SPAT
Assessment of need for aid
2.7
6.6
45
179
S18
ICPC
Laceration/cut
1.7
6.5
199
1426
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
6.5
61
286
G71.08
ICD-10 Finland
Other muscular dystrophy
70.7
6.4
7
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
14.5
6.4
10
7
F43.29
ICD-10 Finland
Adaptation disorder UNS
6.7
6.4
15
23
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.8
6.4
25
68
RF120
NOMESCO Finland
NA
8.3
6.4
13
16
A02BC03
ATC
lansoprazole; oral
1.7
6.4
143
937
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
6.3
60
283
SBA10
NOMESCO Finland
Measurement of excretion of saliva
11.2
6.3
11
10
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
18.3
6.3
9
5
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
6.3
6
*
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
6.3
6
*
H02AB09
ATC
hydrocortisone; systemic
4.6
6.2
20
45
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
6.1
187
1337
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.5
6.1
46
194
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.5
6.1
20
46
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
6.8
6.1
14
21
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
10.2
6.1
11
11
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
6.0
63
312
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
113
16
89.18
213.05
1.4
1.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
158
122
17.93
173.31
6.0
2.2
ug/l
550.0
311.9
0.50
152
115
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
390
1213
9.09
135.17
12.1
2.0
u/l
237.4
268.7
0.22
385
1147
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
108
78
17.08
121.17
1.7
1.1
u/ml
50.0
—
—
10
0
(3037522) Nuclear Ab [Titer] in Serum
236
510
7.47
114.80
1.9
1.3
titre
701.9
398.2
2.63
106
113
(3015171) Extractable nuclear Ab [Units/volume] in Serum
120
131
11.51
103.63
1.5
1.1
u/ml
4.1
3.1
—
8
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
112
117
11.83
99.58
2.2
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
98
100
11.76
88.18
1.5
1.1
u/ml
12.4
3.8
—
25
8
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
97
98
11.86
87.86
1.5
1.1
u/ml
1.8
3.2
—
13
6
(42870588) Differential panel, method unspecified - Blood
319
1382
4.22
59.56
15.3
5.7
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
63
8
89.14
57.37
1.3
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
63
8
89.14
57.37
1.3
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
63
8
89.14
57.37
1.3
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
63
8
89.14
57.37
1.3
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
71
83
9.71
57.23
1.4
1.1
u/ml
54.5
7.0
—
23
5
(3001604) Monocytes [#/volume] in Blood
401
2081
4.66
57.13
16.8
5.6
e9/l
0.6
0.6
0.06
385
1799
(3006315) Basophils [#/volume] in Blood
402
2093
4.66
56.94
16.9
5.6
e9/l
0.0
0.0
0.34
385
1807
(3019198) Lymphocytes [#/volume] in Blood
404
2145
4.57
54.80
16.9
5.6
e9/l
1.7
1.9
3.46
392
1890
(3022096) Basophils/100 leukocytes in Blood
377
1910
4.27
54.58
16.8
5.7
%
0.7
0.7
0.05
369
1779
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
45
27
18.10
54.51
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
45
27
18.10
54.51
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
45
27
18.10
54.51
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
45
28
17.45
53.54
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
45
28
17.45
53.54
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
45
28
17.45
53.54
1.4
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
382
1972
4.25
53.35
17.2
5.7
%
2.6
2.8
1.92
373
1833
(3019069) Monocytes/100 leukocytes in Blood
383
1981
4.25
53.34
17.8
6.0
%
8.8
8.6
0.56
376
1854
(3013115) Eosinophils [#/volume] in Blood
403
2168
4.44
52.83
17.3
5.9
e9/l
0.2
0.2
2.13
391
1910
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
80
122
7.53
51.62
1.6
1.5
iu/ml
300.1
0.2
0.47
11
20
(3002030) Lymphocytes/100 leukocytes in Blood
384
2030
4.13
50.81
17.2
5.8
%
26.2
28.0
2.65
377
1894
(3018010) Neutrophils/100 leukocytes in Blood
381
2005
4.10
50.72
16.7
5.6
%
59.2
57.1
2.73
374
1878
(3013650) Neutrophils [#/volume] in Blood by Automated count
418
2436
4.23
45.75
19.4
9.2
e9/l
4.2
4.1
0.58
401
2148
(3004616) Nuclear Ab [Presence] in Serum
44
42
11.32
40.70
1.7
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
122
376
3.90
34.67
1.8
2.0
nmol/l
358.0
379.7
0.24
115
347
(3017143) Hepatitis C virus Ab [Presence] in Serum
127
440
3.47
29.96
1.5
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
189
838
2.94
29.19
2.0
1.4
g/l
2.2
2.4
0.66
145
496
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
326
1917
2.78
29.08
10.3
5.7
mmol/l
1.2
1.2
0.06
310
1731
(3011412) CD3 cells [#/volume] in Blood
34
37
9.74
28.55
2.1
1.9
e9/l
1.0
1.2
0.33
22
14
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
29
25
12.21
28.48
1.5
1.2
u/ml
2.2
—
—
5
0
(3004588) Protein electrophoresis panel - Serum or Plasma
91
260
4.01
28.47
2.9
2.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
96
287
3.86
28.16
1.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
340
2089
2.71
27.02
11.9
6.5
mmol/l
1.2
1.2
0.44
296
1762
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
142
562
3.08
26.59
1.5
1.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
29
28
10.89
26.44
1.6
1.2
u/ml
103.5
—
—
8
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
124
5.12
26.12
3.0
2.1
g/l
3.1
3.1
0.04
51
100
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
27
24
11.79
25.97
2.3
2.1
%
18.6
12.5
0.94
14
15
(3025159) Blasts/100 leukocytes in Blood
97
310
3.60
25.67
7.4
4.4
%
0.0
0.2
0.94
35
84
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
122
5.11
25.62
3.0
2.1
g/l
10.3
10.6
0.12
51
109
(3017181) Myelocytes/100 leukocytes in Blood
105
356
3.42
25.34
7.4
4.1
%
0.7
1.1
1.04
40
113
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
26
23
11.83
25.07
2.3
2.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
30
33
9.57
24.95
1.6
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
236
1253
2.58
24.78
5.9
3.8
ph
7.4
7.4
1.22
42
237
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
134
4.82
24.73
3.0
2.0
g/l
3.5
3.7
0.80
50
97
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
134
4.82
24.73
3.0
2.0
g/l
7.2
7.3
0.19
52
101
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
134
4.82
24.73
3.0
2.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
294
1738
2.53
24.44
3.2
2.3
nmol/l
76.3
77.4
0.26
277
1542
(3013707) Erythrocyte sedimentation rate by Westergren method
442
3213
3.12
23.61
12.8
3.7
mm/h
14.9
11.8
4.47
429
2945
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
49
102
5.19
22.69
3.3
2.2
g/l
0.0
0.1
0.50
49
96
(3002179) Metamyelocytes/100 leukocytes in Blood
94
319
3.36
22.52
6.7
4.2
%
0.7
0.6
0.34
31
79
(3021440) Promyelocytes/100 leukocytes in Blood
96
332
3.30
22.29
7.7
4.3
%
0.1
0.2
0.83
38
99
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
47
96
5.27
22.23
3.4
2.3
g/l
0.0
0.0
0.00
47
90
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
47
96
5.27
22.23
3.4
2.3
g/l
0.0
0.0
0.00
47
90
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
56
136
4.48
21.56
3.2
2.9
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
81
5.54
21.14
10.0
6.8
iu/ml
519.6
229.8
—
9
12
(3012095) Magnesium [Moles/volume] in Serum or Plasma
143
654
2.62
19.77
6.5
3.5
mmol/l
0.8
0.8
0.71
135
617
(3037467) Urinalysis macro (dipstick) panel - Urine
404
2933
2.52
19.21
8.7
4.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
251
1504
2.26
18.68
5.1
3.6
e6/l
108.8
83.2
0.16
183
1067
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
25
32
8.15
18.43
2.1
1.8
e6/l
364.2
485.6
0.61
18
23
(3035350) Ketones [Presence] in Urine by Test strip
314
2071
2.24
18.32
5.3
3.5
estimate
0.0
0.0
0.00
64
389
(3024561) Albumin [Mass/volume] in Serum or Plasma
281
1784
2.21
17.89
7.2
4.6
g/l
34.1
35.7
4.11
271
1666
(40768443) Skin Pathology biopsy report
61
182
3.65
17.68
1.2
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
33
60
5.79
17.64
1.3
1.8
g/l
0.5
0.8
0.54
26
50
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
141
676
2.47
17.41
2.3
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
212
1212
2.24
17.41
4.6
3.0
ng/l
1086.1
1252.6
0.36
193
1026
(40758558) Short blood count panel - Blood
196
1087
2.26
17.31
13.8
6.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
434
3327
2.59
17.17
16.4
7.1
u/l
73.9
78.4
1.08
429
3098
(3000494) Fungus identified in Specimen by Culture
114
499
2.63
17.00
2.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
314
2111
2.17
16.95
5.4
3.6
estimate
0.0
0.0
0.50
68
376
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
84
314
2.99
16.88
4.3
3.2
ng/l
186.0
177.7
0.08
75
291
(4035726)
95
380
2.82
16.88
1.3
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
23
30
7.96
16.67
1.3
1.1
titre
74.0
95.0
—
10
6
(3021601) Nitrite [Presence] in Urine by Test strip
310
2089
2.14
16.44
7.1
4.9
estimate
0.0
0.0
0.00
67
390
(3023368) Bacteria identified in Blood by Culture
198
1122
2.21
16.43
6.0
3.9
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
23
31
7.71
16.22
2.2
1.8
e9/l
0.2
0.2
0.47
18
23
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
118
537
2.53
16.18
2.9
2.4
%
22.9
23.0
0.02
103
468
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
21
27
8.05
15.38
2.2
2.9
%
41.7
46.1
—
7
7
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
35
79
4.67
14.70
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
43
115
3.98
14.53
1.8
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
42
6.19
14.44
2.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
285
1922
2.03
14.37
20.7
9.1
e9/l
0.0
0.0
0.22
258
1579
(3000850) Epithelial cells [#/volume] in Urine
159
866
2.19
14.23
3.2
2.4
e6/l
2.9
5.8
2.30
144
769
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
118
3.87
14.02
1.3
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
34
78
4.59
14.00
1.5
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
79
4.53
13.78
1.2
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
193
1145
2.07
13.74
4.3
3.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
165
923
2.14
13.72
9.5
4.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
197
1178
2.06
13.72
4.3
3.0
e6/l
0.3
0.5
1.43
159
884
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
32
72
4.66
13.48
1.4
1.4
u/ml
96.3
107.7
—
6
12
(3002582) Erythrocytes [#/volume] in Urine
209
1290
2.02
13.23
4.2
3.1
e6/l
77.0
123.4
0.25
173
993
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
119
3.74
13.09
1.8
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
132
691
2.21
12.89
1.4
1.2
iu/ml
61.6
36.6
0.69
42
221
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
75
4.47
12.83
1.2
1.5
u/ml
289.9
265.6
0.13
22
40
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
71
4.57
12.78
1.3
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
74
300
2.70
12.67
2.4
2.5
au/ml
11.3
18.3
—
5
14
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
166
956
2.07
12.63
1.3
1.2
u/ml
0.8
1.7
0.95
35
254
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
218
1388
1.96
12.45
6.2
3.2
u/l
48.4
31.4
3.11
208
1323
(3003458) Phosphate [Moles/volume] in Serum or Plasma
107
523
2.31
12.28
8.5
5.6
mmol/l
1.1
1.0
0.05
102
486
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
39
110
3.74
12.23
5.7
4.6
mg/l
34.2
31.2
0.12
32
88
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
75
4.33
11.95
5.0
3.3
%
61.2
59.0
0.36
31
75
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
71
4.42
11.88
4.6
3.0
e9/l
4.5
4.7
0.14
30
71
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
100
482
2.32
11.83
2.2
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
95
451
2.34
11.62
2.8
2.8
%
1.7
1.8
0.41
87
408
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
132
719
2.11
11.52
3.4
2.8
e6/l
0.7
1.1
2.04
88
403
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
110
3.64
11.48
5.9
4.6
mg/l
45.1
117.1
0.63
32
87
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
168
1003
1.98
11.38
2.7
2.0
mg/l
3.3
3.2
0.26
151
852
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
83
4.04
11.27
1.8
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
31
6.32
11.27
2.1
2.1
e6/l
924.7
568.9
—
7
14
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
33
89
3.89
11.02
1.8
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
59
4.58
10.84
1.5
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
307
2256
1.84
10.72
8.6
6.1
umol/l
10.0
11.2
2.15
295
2127
(44790049)
25
56
4.63
10.59
1.9
1.5
—
—
—
0
0
(44806118)
25
56
4.63
10.59
1.9
1.5
—
—
—
0
0
(44790047)
25
56
4.63
10.59
1.9
1.5
—
—
—
0
0
(44790048)
25
56
4.63
10.59
1.9
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
96
479
2.22
10.39
2.2
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
84
3.86
10.29
2.1
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
95
475
2.21
10.22
2.1
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
58
4.47
10.15
1.0
1.2
u/ml
3.0
6.0
0.31
11
17
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
295
2.49
10.10
2.1
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
46
4.94
10.09
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
64
272
2.54
9.92
5.9
4.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
11
10.19
9.57
1.9
1.3
ug/l
8.4
8.2
0.05
11
11
(3011397) Hemoglobin [Presence] in Urine by Test strip
157
963
1.89
9.56
5.6
3.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
42
4.91
9.13
2.3
2.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
29
82
3.68
9.07
5.9
5.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
26
69
3.91
8.89
2.0
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
60
4.14
8.88
1.4
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
135
810
1.89
8.70
6.0
3.8
ng/l
235.1
234.0
0.00
115
626
(3027801) Oxygen [Partial pressure] in Arterial blood
90
470
2.10
8.60
13.4
6.8
kpa
10.5
12.3
3.40
80
454
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
90
470
2.10
8.60
13.4
6.8
kpa
5.2
5.1
0.30
80
453
(3019309) Folate [Moles/volume] in Red Blood Cells
127
751
1.91
8.54
1.8
1.7
nmol/l
1121.8
1178.5
0.31
103
568
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
29
5.66
8.54
1.1
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
12
6
20.41
8.50
1.8
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
248
1791
1.71
8.48
3.6
2.7
ug/l
189.2
119.3
2.23
236
1646
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
19
6.99
8.48
2.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
49
4.42
8.47
1.7
1.9
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
12
16
7.65
8.44
1.0
1.1
ratio
1.1
1.1
—
6
5
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
67
3.86
8.43
1.0
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
208
1436
1.73
8.34
3.5
3.3
mmol/l
2.3
2.4
1.96
191
1256
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
54
4.21
8.33
1.7
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
353
2820
1.73
8.21
6.3
4.4
e6/l
15.4
2715.0
—
5
46
(3048929) Epstein Barr virus Ab [Presence] in Serum
36
125
3.02
8.18
1.2
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
64
3.88
8.15
2.0
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
70
338
2.23
8.14
2.9
2.3
ug/l
18.4
6.6
2.44
61
295
(3026389) Candida sp identified in Specimen by Organism specific culture
21
51
4.24
8.06
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
117
686
1.90
8.04
1.8
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
88
469
2.05
7.94
13.7
6.9
mmol/l
1.5
1.2
0.22
67
376
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
70
3.70
7.94
1.4
1.5
—
—
—
0
0
(4062490)
17
35
4.98
7.93
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
39
4.74
7.93
1.2
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
107
614
1.93
7.83
2.9
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
164
1078
1.75
7.72
4.0
2.6
umol/l
2701.3
7702.7
1.09
151
930
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
115
681
1.88
7.63
1.3
1.2
u/ml
33.8
14.9
0.52
33
258
(3014148) Varicella zoster virus Ab [Titer] in Serum
19
45
4.34
7.53
1.1
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
189
1301
1.70
7.49
2.7
2.3
u/l
54.4
55.6
0.23
174
1197
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
59
3.85
7.42
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
189
1304
1.69
7.41
3.1
3.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
7
16.00
7.25
1.9
2.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
90
500
1.96
7.21
2.1
2.2
ug/g
193.3
125.9
0.65
76
393
(3032080) INR in Blood by Coagulation assay
234
1718
1.64
7.16
10.1
8.5
inr
1.2
1.2
0.07
61
508
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
23
5.77
7.09
1.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
112
673
1.84
7.06
3.8
2.9
e6/l
3.3
2.3
0.66
70
362
(3052851) Hemolysis interference index of Serum or Plasma
33
120
2.86
6.93
3.0
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
25
77
3.36
6.91
1.4
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
150
989
1.72
6.87
1.7
1.5
nmol/l
19.7
21.3
0.79
132
833
(3044927) Protein electrophoresis panel - Urine
17
40
4.36
6.79
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
63
3.60
6.78
1.0
1.2
u/ml
2.4
4.6
—
8
30
(3013826) Glucose [Moles/volume] in Serum or Plasma
311
2481
1.60
6.56
8.9
4.5
mmol/l
6.6
6.7
0.38
298
2313
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
47
210
2.36
6.55
18.1
8.7
mmol/l
24.7
24.6
0.06
42
199
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
85
479
1.92
6.51
3.4
3.0
umol/l
6.5
8.0
0.57
72
420
(36660697) Celiac disease serology panel - Serum
64
327
2.09
6.44
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
64
327
2.09
6.44
17.6
8.3
—
—
—
0
0
(3036489) Thrombin time
37
149
2.59
6.42
3.0
2.7
s
21.7
22.0
0.17
32
133
(3023419) Bacteria identified in Sputum by Culture
19
52
3.75
6.25
2.4
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
127
822
1.71
6.15
3.5
2.6
mosm/kgh2o
559.5
548.6
0.20
113
706
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
19
5.89
6.13
1.7
3.2
u/ml
1187.1
998.7
0.23
11
19
(3000093) Morphology [Interpretation] in Blood Narrative
16
39
4.20
6.13
1.3
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
75
418
1.92
5.92
15.5
7.3
%
94.6
95.6
0.67
68
406
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
6
15.22
5.92
1.1
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
155
1067
1.64
5.91
6.7
3.7
%
91.4
92.0
0.11
149
1041
(3023520) Reticulocytes [#/volume] in Blood
63
331
2.02
5.89
2.6
2.9
e9/l
69.0
73.6
0.38
44
255
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
20
5.59
5.83
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
28
4.73
5.76
2.8
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
98
2.85
5.71
1.2
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
46
3.78
5.68
4.9
4.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
37
4.14
5.66
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
54
272
2.10
5.65
3.7
2.4
e9/l
3.7
4.1
0.39
42
214
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
17
5.97
5.64
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
17
5.97
5.64
1.0
1.1
—
—
—
0
0
(4306422)
19
56
3.48
5.63
1.2
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
162
1142
1.60
5.56
4.4
3.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
29
4.57
5.54
1.5
3.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
57
3.42
5.49
2.2
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
38
4.03
5.47
2.5
3.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
215
1623
1.54
5.45
5.2
3.5
ng/l
95.2
37.1
2.35
181
1113
(3029937) Albumin [Presence] in Urine by Test strip
159
1122
1.59
5.41
6.5
3.8
estimate
0.0
0.0
0.00
67
383
(3045424) Erythrocytes [Presence] in Urine
21
68
3.17
5.40
1.6
1.5
—
—
—
0
0
(4268621)
16
44
3.72
5.24
1.8
2.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
49
3.55
5.21
1.4
1.4
%
12.2
65.0
—
9
35
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
6
13.51
5.09
1.0
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
9
10.14
5.04
1.1
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
9
10.14
5.04
4.8
2.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
46
3.55
4.93
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
46
3.55
4.93
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
46
3.55
4.93
1.5
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
113
2.56
4.87
5.0
2.5
u/ml
0.4
0.4
0.01
19
55
(3045414) Leukocytes [Presence] in Urine
38
177
2.23
4.84
1.9
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
91
2.71
4.72
2.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
134
2.39
4.68
1.4
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
29
4.21
4.65
1.1
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
135
947
1.57
4.63
2.2
1.8
mg/l
1.2
1.1
0.21
101
747
(42529406) Shigella sp [Presence] in Stool by Culture
31
135
2.38
4.61
1.4
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
43
215
2.09
4.61
2.1
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
11
8.30
4.57
1.1
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
220
1720
1.47
4.49
2.2
2.0
pmol/l
95.1
94.9
0.02
121
871
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
82
2.75
4.47
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
207
1604
1.47
4.40
5.9
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
91
587
1.66
4.38
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
132
2.35
4.37
1.3
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
115
2.42
4.23
1.5
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
13
7.02
4.17
1.3
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
32
3.81
4.10
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
23
92
2.57
4.10
1.5
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
23
92
2.57
4.10
1.5
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
7
7
10.11
4.02
1.0
1.1
u/ml
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
80
511
1.66
3.99
27.5
22.3
inr
1.7
1.3
—
8
70
(1761868) Lipid panel - Serum or Plasma
110
1521
0.65
3.88
2.7
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
44
238
1.92
3.83
2.0
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
60
2.89
3.82
2.9
2.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
5
12.11
3.77
1.0
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
16
5.70
3.67
3.3
1.7
ug/l
61.6
53.1
—
9
16
(3002032) Base excess in Venous blood by calculation
61
374
1.71
3.55
6.0
4.4
mmol/l
2.1
2.0
0.10
53
302
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
17
5.36
3.52
1.0
1.1
iu/ml
90.7
225.5
—
9
17
(3024471) HLA-A [Type]
8
13
6.23
3.51
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
13
6.23
3.51
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
160
2.06
3.47
2.7
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
467
4325
1.61
3.45
31.5
13.1
mg/l
19.4
23.2
2.40
431
3385
(3019225) pH of Specimen
66
418
1.66
3.41
7.1
4.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
112
803
1.50
3.40
2.4
2.8
mmol/l
2.5
2.5
1.01
94
715
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
42
3.15
3.39
1.6
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
18
5.07
3.38
1.0
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
40
219
1.89
3.38
4.6
4.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
14
5.78
3.35
1.3
1.6
—
—
—
0
0
(3000492) Spirometry study
63
398
1.66
3.29
2.4
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
9
19
4.80
3.25
1.7
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
62
392
1.66
3.23
18.3
7.5
g/l
120.7
121.2
0.07
57
381
(3022145) Colonoscopy Study observation
75
498
1.59
3.21
1.3
1.3
—
—
—
0
0
(4015189)
7
11
6.43
3.19
1.3
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
145
2.06
3.16
2.7
4.0
g/l
0.3
0.2
—
10
56
(3020891) Body temperature
31
159
2.01
3.16
7.9
4.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
118
868
1.46
3.14
1.6
1.8
pmol/l
63636809.2
6983681.2
0.42
110
716
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
64
412
1.63
3.11
2.3
2.3
u/l
361.3
34.0
0.49
55
350
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
211
1.86
3.09
24.4
8.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
34
3.28
3.07
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
93
2.31
3.07
5.0
2.9
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
10
29
3.49
3.06
1.2
1.2
mg/l
63.9
32.3
—
10
23
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
120
2.14
3.03
1.6
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
43
250
1.78
3.03
1.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
222
1.82
2.94
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
54
338
1.66
2.93
6.0
3.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
25
122
2.10
2.92
7.8
6.5
mmol/l
1.2
1.3
0.21
17
108
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
64
2.55
2.89
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
90
2.27
2.83
9.2
3.2
mmol/l
2.8
3.1
0.21
15
56
(3000475) Leukocytes [#/volume] in Synovial fluid
22
104
2.16
2.78
1.7
1.6
e6/l
4675.6
18923.4
1.40
16
76
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
319
2809
1.33
2.71
4.1
3.1
u/l
54.1
46.3
0.92
306
2616
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
393
4244
0.72
2.70
4.9
4.4
mmol/l
1.4
1.5
4.07
370
3910
(40768441) Liver Pathology biopsy report
10
32
3.17
2.66
2.1
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
207
1.79
2.65
1.0
1.0
—
—
—
0
0
(4027681)
9
25
3.64
2.58
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
119
908
1.40
2.57
6.9
3.9
kg/l
1.0
1.0
0.25
19
131
(3041806) Other cells [#/volume] in Blood by Manual count
5
7
7.20
2.55
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
7
7.20
2.55
3.8
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
397
4269
0.73
2.52
4.8
4.4
mmol/l
4.8
4.7
1.77
373
3945
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
26
3.50
2.49
1.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
42
259
1.67
2.44
11.7
7.0
mmol/l
24.9
24.6
0.17
37
245
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
125
1.96
2.39
1.3
1.3
ug/g
300.9
297.5
0.03
16
75
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
368
0.50
2.38
1.7
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
147
1.88
2.37
2.5
1.7
—
—
—
0
0
(4010399)
49
317
1.60
2.37
2.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
22
3.67
2.37
1.3
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
22
3.67
2.37
1.3
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
22
3.67
2.37
1.5
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
378
4079
0.75
2.30
4.5
4.0
mmol/l
1.5
1.3
3.80
356
3740
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
121
1.94
2.24
1.3
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
408
4351
0.74
2.24
5.1
5.0
mmol/l
2.9
2.8
2.25
386
4001
(3022806) Fractional oxyhemoglobin in Capillary blood
13
54
2.44
2.21
3.4
1.7
%
90.5
89.7
0.30
13
54
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
42
2.65
2.19
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
96
2.02
2.08
1.4
1.6
iu/l
4.4
6.1
—
8
28
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
20
3.53
2.06
1.7
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
20
3.53
2.06
1.7
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
20
3.53
2.06
3.4
2.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
20
3.53
2.06
1.1
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
20
3.53
2.06
1.7
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
38
2.66
2.02
1.5
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
11
4.58
1.94
2.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
11
4.58
1.94
2.0
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.6
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
59
2.23
1.85
1.2
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
40
2.53
1.84
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
12
4.20
1.82
1.2
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
12
4.20
1.82
2.6
4.0
%
55.6
48.2
—
5
12
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
60
2.20
1.79
1.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
41
2.47
1.76
1.2
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
38
250
1.56
1.76
3.4
2.9
pmol/l
4.2
4.6
1.52
32
216
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
18
3.36
1.75
2.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
36
2.52
1.74
3.6
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
36
235
1.57
1.73
1.3
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
19
3.18
1.66
5.2
3.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
19
3.18
1.66
1.0
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
2.5
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
19
3.18
1.66
2.5
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
19
3.18
1.66
1.2
1.2
nmol/l
157.7
159.7
—
6
19
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
250
0.51
1.65
1.4
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
70
2.03
1.60
1.4
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
26
2.71
1.58
1.6
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
15
3.35
1.52
1.0
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
355
3292
1.23
1.49
4.9
3.9
pmol/l
15.0
14.8
0.61
332
2969
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
45
2.25
1.47
1.2
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
117
1.74
1.47
1.3
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
28
2.52
1.45
2.1
1.4
g/l
1.0
1.0
—
7
28
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
16
3.14
1.44
1.0
1.0
miu/ml
1323.8
1259.4
—
5
16
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
22
2.75
1.44
2.5
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
22
2.75
1.44
2.5
1.6
—
—
—
0
0
(4211845)
6
22
2.75
1.44
5.2
3.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
29
2.43
1.39
1.1
1.3
—
24.0
—
0
5
(3044290) Cell count panel - Cerebral spinal fluid
16
89
1.82
1.38
1.6
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
6
23
2.63
1.37
2.2
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
113
1.71
1.33
2.1
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
43
2.11
1.31
4.0
3.3
—
—
—
0
0
(3035880) pH of Pleural fluid
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
117
0.42
1.26
1.0
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
36
2.24
1.24
1.6
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
45
2.02
1.24
1.2
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
19
2.65
1.22
3.6
3.9
nmol/l
1051.6
84.6
—
5
19
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
439
1.33
1.20
5.3
3.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
50
2.02
1.17
1.5
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
39
2.07
1.15
1.3
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
223
2014
1.18
1.13
5.0
3.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
135
1.58
1.13
1.5
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
58
453
1.31
1.12
2.5
4.0
ug/l
3.0
31.8
1.00
46
377
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
10
51
1.98
1.12
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
163
0.54
1.10
2.4
2.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
66
1.84
1.09
1.3
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
32
2.20
1.08
1.6
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
97
1.67
1.07
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
151
0.52
1.04
1.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
22
2.28
1.03
1.2
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
91
1.67
1.01
1.9
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
194
1746
1.17
1.01
2.5
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
35
2.01
1.00
2.1
3.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
153
1351
1.19
0.99
2.9
2.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.2
—
5.8
—
0
7
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
20.1
—
1707.2
—
0
31
(3016879) Cocaine [Presence] in Urine
8
142
0.56
0.94
1.0
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
37
1.90
0.94
2.1
1.1
nmol/l
1.9
1.5
—
7
32
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
28
2.16
0.91
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
138
1218
1.18
0.90
3.3
3.2
mg/l
2368.4
109.6
1.53
97
763
(3027008) Opiates [Presence] in Urine
9
152
0.59
0.90
1.0
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
152
0.59
0.90
1.0
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
42
1.92
0.89
1.9
1.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
42
1.92
0.89
2.3
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
117
1024
1.18
0.84
2.8
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
411
3949
1.17
0.84
5.6
4.7
mu/l
1.9
2.2
0.45
389
3590
(3000764) Benzodiazepines [Presence] in Urine
9
151
0.59
0.79
1.0
1.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
124
0.56
0.78
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
99
0.50
0.78
1.0
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
41
325
1.28
0.76
1.5
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
54
1.68
0.75
1.8
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
54
1.68
0.75
1.8
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
55
1.65
0.74
1.8
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
55
1.65
0.74
1.8
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
55
1.65
0.74
1.8
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
55
1.65
0.74
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
55
1.65
0.74
1.8
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
38
1.85
0.73
2.0
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
386
0.76
0.71
2.6
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
93
1.52
0.70
3.2
2.2
g/l
114.0
131.8
—
7
69
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
93
1.52
0.70
3.0
3.8
mg/l
31.7
27.1
—
8
54
(21494755) Public health laboratory ask at order entry panel
30
382
0.77
0.66
1.3
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
23
171
1.36
0.66
7.3
5.1
%
1.1
0.9
1.63
18
162
(3024928) Oxygen saturation in Venous blood
13
86
1.52
0.66
11.5
3.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
35
278
1.28
0.65
3.2
2.9
—
—
—
0
0
(4146454)
7
44
1.60
0.65
1.7
2.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.4
—
3.2
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
116
0.60
0.58
2.4
4.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
98
1.44
0.57
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
143
1310
1.12
0.56
3.2
3.2
mmol/l
6.7
7.4
1.24
124
1087
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
406
4176
0.89
0.56
4.9
4.5
mmol/l
5.7
5.9
4.06
378
3808
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
85
755
1.15
0.54
1.5
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
74
1.50
0.53
3.6
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
91
1.44
0.53
1.1
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
91
1.44
0.53
4.2
2.3
%
15.2
16.5
—
5
46
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
39
1.54
0.53
3.0
3.3
nmol/l
7.6
6.6
—
6
39
(3028626) Oxygen [Partial pressure] in Capillary blood
16
117
1.38
0.53
3.6
3.2
kpa
8.3
8.5
0.11
16
105
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
44
370
1.21
0.52
1.3
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
43
361
1.21
0.52
5.6
3.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
40
1.51
0.51
2.0
2.2
%
13.7
13.2
—
6
40
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
22
171
1.30
0.50
7.5
5.0
%
2.0
1.6
1.72
17
161
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
146
1.31
0.47
1.6
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
63
554
1.16
0.46
1.4
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
117
0.68
0.46
1.5
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
383
3935
0.91
0.45
33.7
14.4
%
39.3
39.8
0.60
266
2819
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
86
1.40
0.45
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
151
0.72
0.43
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
57
1.41
0.42
1.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
71
1.42
0.39
1.2
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
0.2
—
0
7
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
1.6
1.1
—
—
—
0
0
(1002224) Polysomnography panel
23
188
1.23
0.38
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
69
1.31
0.37
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
426
0.86
0.36
2.4
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
392
4007
0.92
0.35
6.2
5.7
mmol/mol
39.9
39.7
0.22
373
3718
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
40
349
1.16
0.35
2.8
2.6
ml/min/173m2
72.8
67.6
0.18
12
150
(40768795) Lymph node Pathology biopsy report
6
46
1.31
0.33
1.3
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
56
504
1.12
0.32
1.4
1.7
%
1.5
1.5
0.06
45
446
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
468
4615
1.11
0.32
25.1
10.0
u/l
31.0
25.8
6.91
461
4444
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
52
1.35
0.31
1.6
1.9
pg
33.1
32.4
—
7
52
(3013512) EKG study
133
1254
1.08
0.31
4.2
3.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
56
1.25
0.29
1.0
1.3
nmol/l
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
451
4446
1.09
0.28
29.7
15.4
mmol/l
139.4
139.7
1.94
441
4329
(3010813) Leukocytes [#/volume] in Blood
476
4811
0.91
0.27
42.6
19.9
e9/l
7.0
6.6
2.17
468
4680
(3026361) Erythrocytes [#/volume] in Blood
476
4810
0.91
0.26
42.6
19.8
e12/l
4.4
4.5
4.71
468
4681
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
74
1.22
0.25
5.6
2.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
32
283
1.14
0.25
1.3
1.2
iu/ml
96.1
129.3
—
8
110
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
416
4096
1.07
0.24
24.3
12.5
ml/min/173m2
86.6
81.3
4.26
369
3343
(3043409) Potassium [Moles/volume] in Arterial blood
16
133
1.21
0.24
9.8
3.6
mmol/l
3.9
3.9
0.08
16
122
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
87
927
0.93
0.24
3.6
4.3
%
22.1
21.5
0.18
44
430
(3021901) Oxygen saturation in Capillary blood
10
78
1.29
0.24
4.3
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
135
1287
1.07
0.24
3.9
4.0
mg/mmol
7.2
8.6
0.23
85
794
(3007461) Platelets [#/volume] in Blood
476
4806
0.92
0.23
42.7
19.8
e9/l
262.3
250.4
2.27
469
4686
(3012441) Differential panel - Pleural fluid
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(4024509)
5
39
1.28
0.23
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
91
0.77
0.22
1.3
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
40
1.25
0.22
1.2
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
73
685
1.08
0.20
1.6
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
1.6
—
0
9
(3023103) Potassium [Moles/volume] in Serum or Plasma
451
4462
1.07
0.19
30.0
15.6
mmol/l
3.9
4.0
2.52
441
4333
(3044889) 12 lead EKG panel
308
3021
1.05
0.18
5.3
3.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
147
1.16
0.18
2.0
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
142
0.84
0.17
1.2
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
61
1.15
0.17
2.1
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
12
101
1.19
0.16
1.8
2.2
u/l
13609.2
3223.3
—
6
33
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
120
1156
1.05
0.15
4.6
4.9
ug/l
3.9
2.4
0.68
109
1039
(3039443) Prostate specific Ag panel - Serum or Plasma
6
77
0.78
0.15
1.8
1.6
—
—
—
0
0
(4034850)
15
133
1.13
0.12
23.7
9.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
280
1.08
0.10
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
44
1.14
0.10
1.0
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
46
1.09
0.09
7.4
5.6
mmol/l
6.8
6.4
—
5
38
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
43
452
0.95
0.09
1.6
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
213
1.08
0.09
2.2
3.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
54
1.11
0.09
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
165
0.91
0.09
2.1
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
55
1.09
0.09
2.8
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
454
4515
1.04
0.08
23.7
12.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
60
0.83
0.08
1.6
1.3
mmol/l
7.8
7.5
—
5
40
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
88
1.14
0.08
1.6
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
84
0.83
0.07
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
214
0.93
0.07
2.0
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
57
552
1.04
0.06
4.8
4.5
%
29.9
31.7
0.73
44
356
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
262
2645
0.98
0.06
3.1
2.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
121
1196
1.02
0.03
1.6
1.7
mmol/l
1.6
1.4
2.12
103
1008
(3003694) ABO and Rh group [Type] in Blood
115
1162
0.99
0.02
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
69
682
1.01
0.01
2.7
3.0
ug/l
0.7
0.8
0.18
48
441
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
52
526
0.99
0.00
8.9
6.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
188
1.01
0.00
2.1
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
131
0.99
0.00
1.8
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.6
—
0
5
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
4.8
—
8.1
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
67.4
—
0
5
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
8.5
—
0.4
—
0
6
(3025315) Body weight
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.8
—
0
7
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
61
0.98
0.00
2.2
2.6
—
22.7
—
0
15
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
51
0.98
0.00
1.4
1.5
u/l
31.3
30.3
—
5
42
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
60
1.00
0.00
1.3
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: M13_DERMATOPOLY – Dermatopolymyositis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).